USask VIDO-InterVac expands international role to test antiviral compounds against COVID-19

USask VIDO-InterVac expands international role to test antiviral compounds against COVID-19

Ce contenu n'est disponible qu'en anglais.

The Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan (USask) has been awarded a grant of almost $830,000 from the COVID-19 Therapeutics Accelerator to determine the effectiveness of several antiviral compounds against COVID-19....

https://www.vido.org/news/usask-vido-intervac-expands-international-role-to-test-antiviral-compounds-against-covid-19